Patents by Inventor Dharam V. Ablashi

Dharam V. Ablashi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF TREATING INFECTIONS USING SILOXANE DERIVATIVES
    Publication number: 20180064738
    Abstract: Pharmaceutical compositions are disclosed that comprise at least one compound of formula I: wherein the substituent groups are as defined in the specification, and a pharmaceutically-acceptable excipient. The disclosed pharmaceutical compositions are anti-infective and useful as therapies for the treatment of an infection, including infections associated with a bacteria or a virus. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Application
    Filed: October 7, 2015
    Publication date: March 8, 2018
    Inventors: Bhupesh Kumar PRUSTY, Dharam V. ABLASHI, Kirk KIMMERLING
  • Antibodies against human herpesvirus-6(HHV-6) and method of use
    Patent number: 6054283
    Abstract: A new human B lymphotropic virus, also designated human herpesvirus-6, has been isolated. DNA, molecular clones, antigenic viral proteins and antibodies having specificity to the new virus have been prepared. Various utilities of the new virus and products derived therefrom have been described.
    Type: Grant
    Filed: December 23, 1996
    Date of Patent: April 25, 2000
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Syed Zaki Salahuddin, Dharam V. Ablashi, Steven F. Josephs, Carl W. Saxinger, Flossie Wong-Staal, Robert C. Gallo
  • Human herpesvirus-6 (HHV-6) isolation and products
    Patent number: 6018027
    Abstract: A new human B lymphotropic virus, also designated human herpesvirus-6, has been isolated. DNA, molecular clones, antigenic viral proteins and antibodies having specificity to the new virus have been prepared. Various utilities of the new virus and products derived therefrom have been described.
    Type: Grant
    Filed: December 30, 1997
    Date of Patent: January 25, 2000
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Syed Zaki Salahuddin, Dharam V Ablashi, Steven F. Josephs, Carl W. Saxinger, Flossie Wong-Staal, Robert C. Gallo
  • Human herpesvirus-6(HHV-6)Isolution and Products
    Patent number: 5604093
    Abstract: A new human B lymphotropic virus, also designated human herpesvirus-6, has been isolated. DNA, molecular clones, antigenic viral proteins and antibodies having specificity to the new virus have been prepared. Various utilities of the new virus and products derived therefrom have been described.
    Type: Grant
    Filed: February 22, 1995
    Date of Patent: February 18, 1997
    Assignee: The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services
    Inventors: Syed Z. Salahuddin, Dharam V. Ablashi, Steven F. Josephs, Carl W. Saxinger, Flossie Wong-Staal, Robert C. Gallo
  • Antibodies against human herpes virus-6(HHV-6) and method of use
    Patent number: RE38824
    Abstract: A new human B lymphotropic virus, also designated human herpesvirus-6, has been isolated. DNA, molecular clones, antigenic viral proteins and antibodies having specificity to the new virus have been prepared. Various utilities of the new virus and products derived therefrom have been described.
    Type: Grant
    Filed: March 1, 2002
    Date of Patent: October 11, 2005
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Syed Z. Salahuddin, Dharam V. Ablashi, Steven F. Josephs, Carl W. Saxinger, Flossie Wong-Staal, Robert C. Gallo